Articles from Antech
Antech, a global leader in veterinary diagnostics and a Mars Science & Diagnostics company, today announced the launch of the Antech Veterinary Futures Scholarship. In partnership with Vet Set Go®, the annual scholarship program supports aspiring veterinary professionals by rewarding them for gaining significant real-world experience.
By Antech · Via Business Wire · April 21, 2026
Antech™, a global veterinary diagnostics company, today announced the launch of RapidRead Dental for Feline, an AI-powered dental radiograph analysis solution built specifically for cats, and the addition of SDMA testing to its in-house diagnostic platform, Element i+. Both innovations will be spotlighted at the 2026 Veterinary Meeting & Expo (VMX).
By Antech · Via Business Wire · January 13, 2026
Antech™, a global veterinary diagnostics company, today announced the Canadian Food Inspection Agency (CFIA) has granted regulatory approval for trūRapid™ FOUR, a comprehensive in-house canine vector-borne disease screening test, and trūRapid™ FIV/FeLV, a two-in-one infectious disease test that simultaneously screens for Feline Immunodeficiency Virus (FIV) antibodies and Feline Leukemia Virus (FeLV) antigen. These rapid lateral-flow tests provide in-house screening for veterinary clinics and animal care facilities, supporting early detection using whole blood, serum, or plasma.
By Antech · Via Business Wire · October 20, 2025
ANTECH, a global veterinary diagnostics, technology and imaging company, today announced the launch of RapidRead Dental, an Artificial Intelligence (AI) powered radiology interpretation tool, that delivers accurate dental radiograph evaluations in approximately 10 minutes. Developed by Board-Certified Veterinary Dentists using over 55,000 images and 275,000 teeth, the tool offers comprehensive tooth-by-tooth analysis with 98% accuracy.
By ANTECH · Via Business Wire · May 20, 2025
Antech™, a global veterinary diagnostics, technology and imaging company, today announced the launch of two new vector-borne disease diagnostics in their expanding portfolio: enhanced Accuplex™, a reference lab canine vector-borne disease (CVBD) screening test which now detects seven pathogens, and an enhanced vector-borne disease PCR profile, the veterinary industry’s most comprehensive PCR panel of its kind.
By Antech · Via Business Wire · May 12, 2025

Antech, a global veterinary diagnostics, technology and imaging company, today announced the launch of trūRapid™ FOUR, a comprehensive in-house canine vector-borne disease (CVBD) screening test.
By Antech · Via Business Wire · March 10, 2025

Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the availability of two new breakthrough innovations to mark a new chapter for veterinary diagnostics. Available now are AIS RapidRead to enable faster interpretations of radiographs and the in-house Nu.Q® Canine Cancer Test, two innovations that support clinical decision-making to improve patient outcomes.
By Antech · Via Business Wire · April 12, 2024
